Today, I talk to Rick Doblin, the Founder and Executive Director of MAPS (Multidisciplinary Association for Psychedelic Studies) A “non-profit research and educational organisation that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.” Some people say Rick is a “Mensch” and that’s yiddish for a a person of integrity and honour, which I would like to confirm 100% regarding Now, after decades of focused, strategic effort, MAPS has achieved securing FDA approval to conduct a Phase III study of a psychedelic drug – in this case MDMA – for treatment-resistant PTSD.
